ArticleTranslational andrology and urology2020

Phosphodiesterase type 5 inhibitor therapy provides sustained relief of symptoms among patients with chronic pelvic pain syndrome.

Kevin Pineault et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.